Creso Pharma Limited (CPH:ASX)

11.0¢

right-arrow Created with Sketch. -0.005 (-4.35%)
MCAP $138.1M
Last trade 16.10pm 24/09/2021 20mins delayed

Latest Announcements

20/09/2021 Price SensitivePSCPHCreso Pharma Limited
20/09/2021 Price SensitivePSCPHCreso Pharma Limited
4,666
MCap
17/09/2021CPHCreso Pharma Limited
13/09/2021CPHCreso Pharma Limited
13/09/2021CPHCreso Pharma Limited
09/09/2021CPHCreso Pharma Limited
06/09/2021CPHCreso Pharma Limited
06/09/2021CPHCreso Pharma Limited

Company Overview

Creso Pharma Limited is an Australia-based cannabis company. The Company is engaged in developing cannabis and hemp-derived therapeutic-grade nutraceuticals and medical cannabis products with a range of applications in both human and animal health. The Company, through its subsidiary is also engaged in cultivates and harvests cannabis plants and supplies dried cannabis plant retail products. The Company is operating medical facility in Windsor, Nova Scotia with 6 treatment rooms and a laboratory dedicated to performing psychedelic-assisted psychotherapy and clinical research.

CPH in the news

Creso Pharma’s (CPH) subsidiary Halucenex Life Sciences will work with a Canadian…
Creso Pharma (CPH) launches new ecommerce channels and expands into Poland with…
Creso Pharma (CPH) is looking to land on another US exchange after…
Creso Pharma’s (CPH) subsidiary, Halucenex, is being awarded a dealer’s licence in…

Search Previous Announcements